Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
NMR Biomed ; 23(8): 931-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20878971

ABSTRACT

Manganese-enhanced magnetic resonance imaging (MEMRI) is a novel imaging technique capable of monitoring calcium influx, in vivo. Manganese (Mn2+) ions, similar to calcium ions (Ca2+), are taken up by activated cells where their paramagnetic properties afford signal enhancement in T(1)-weighted MRI methodologies. In this study we have assessed Mn2+ distribution in mice using magnetization-prepared rapid gradient echo (MP-RAGE) based MRI, by measuring changes in T(1)-effective relaxation times (T(1)-eff), effective R(1)-relaxation rates (R(1)-eff) and signal intensity (SI) profiles over time. The manganese concentration in the tissue was also determined using inductively coupled plasma atomic emission spectrometry (ICP-AES). Our results show a strong positive correlation between infused dose of MnCl2 and the tissue manganese concentration. Furthermore, we demonstrate a linear relationship between R(1)-eff and tissue manganese concentration and tissue-specific Mn2+ distribution in murine tissues following dose-dependent Mn2+ administration. This data provides an optimized MnCl2 dose regimen for an MP-RAGE based sequence protocol for specific target organs and presents a potential 3D MRI technique for in vivo imaging of Ca2+ entry during Ca2+-dependent processes in a wide range of tissues.


Subject(s)
Chlorides , Image Enhancement/methods , Magnetic Resonance Imaging/methods , Manganese Compounds , Manganese , Animals , Chlorides/administration & dosage , Chlorides/metabolism , Male , Manganese/chemistry , Manganese/metabolism , Manganese Compounds/administration & dosage , Manganese Compounds/metabolism , Mice , Mice, Inbred C57BL , Tissue Distribution
2.
Toxicol Lett ; 188(3): 223-9, 2009 Aug 10.
Article in English | MEDLINE | ID: mdl-19464128

ABSTRACT

Lanthanum carbonate is a non-calcium phosphate binder used to control hyperphosphataemia in patients with chronic kidney disease who are undergoing dialysis. Ultrastructurally, lanthanum ions are too large to traverse the tight junctions in the blood-brain barrier, yet tissue distribution studies using dietary administration have reported low concentrations in rodent brain, raising concern about accumulation. To investigate this, tissue lanthanum concentrations were measured in rats given the same lanthanum carbonate dose via powdered diet or oral gavage (838 and 863 mg/kg/day). Additional rats were dosed intravenously with lanthanum chloride (0.03 mg/kg/day), a route enabling much higher plasma lanthanum concentrations. After 28 days, median lanthanum concentrations in liver, bone, kidney and heart showed a direct relationship with those in plasma (highest after intravenous and lowest after dietary dosing). In contrast, brain concentrations were dramatically higher after dietary administration (< or =500 ng/g), compared to the other routes (LLOQ of 11 ng/g). An identical skewed pattern was noted for skin, a tissue readily contaminated in powdered diet studies. These data indicate that brain deposition is a contamination artefact caused by transfer of lanthanum from cranial skin to brain as animals are manipulated during autopsy. Dietary administration should be avoided in distribution studies of trace elements due to the high contamination risk.


Subject(s)
Brain/metabolism , Drug Contamination , Drug Evaluation, Preclinical/methods , Lanthanum/administration & dosage , Lanthanum/pharmacokinetics , Administration, Oral , Animals , Biological Availability , Blood-Brain Barrier/metabolism , Dose-Response Relationship, Drug , Female , Injections, Intravenous , Lanthanum/adverse effects , Male , Organ Specificity , Rats , Tissue Distribution
3.
J Biol Chem ; 284(27): 18377-89, 2009 Jul 03.
Article in English | MEDLINE | ID: mdl-19377097

ABSTRACT

Zinc ions play indispensable roles in biological chemistry. However, bacteria have an impressive ability to acquire Zn(2+) from the environment, making it exceptionally difficult to achieve Zn(2+) deficiency, and so a comprehensive understanding of the importance of Zn(2+) has not been attained. Reduction of the Zn(2+) content of Escherichia coli growth medium to 60 nm or less is reported here for the first time, without recourse to chelators of poor specificity. Cells grown in Zn(2+)-deficient medium had a reduced growth rate and contained up to five times less cellular Zn(2+). To understand global responses to Zn(2+) deficiency, microarray analysis was conducted of cells grown under Zn(2+)-replete and Zn(2+)-depleted conditions in chemostat cultures. Nine genes were up-regulated more than 2-fold (p < 0.05) in cells from Zn(2+)-deficient chemostats, including zinT (yodA). zinT is shown to be regulated by Zur (zinc uptake regulator). A mutant lacking zinT displayed a growth defect and a 3-fold lowered cellular Zn(2+) level under Zn(2+) limitation. The purified ZinT protein possessed a single, high affinity metal-binding site that can accommodate Zn(2+) or Cd(2+). A further up-regulated gene, ykgM, is believed to encode a non-Zn(2+) finger-containing paralogue of the Zn(2+) finger ribosomal protein L31. The gene encoding the periplasmic Zn(2+)-binding protein znuA showed increased expression. During both batch and chemostat growth, cells "found" more Zn(2+) than was originally added to the culture, presumably because of leaching from the culture vessel. Zn(2+) elimination is shown to be a more precise method of depleting Zn(2+) than by using the chelator N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine.


Subject(s)
Escherichia coli Proteins/metabolism , Escherichia coli/metabolism , Ribosomal Proteins/metabolism , Zinc/metabolism , Binding Sites , Binding, Competitive/physiology , Biological Transport/physiology , Escherichia coli/genetics , Escherichia coli/growth & development , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/genetics , Fluorescent Dyes/metabolism , Fura-2/analogs & derivatives , Fura-2/metabolism , Gene Expression Profiling , Gene Expression Regulation, Bacterial/physiology , Microbiological Techniques , Oligonucleotide Array Sequence Analysis , Protein Structure, Tertiary , Ribosomal Proteins/chemistry , Ribosomal Proteins/genetics , Zinc/deficiency
4.
J Biol Chem ; 284(7): 4516-24, 2009 Feb 13.
Article in English | MEDLINE | ID: mdl-19091747

ABSTRACT

Carbon monoxide, a classical respiratory inhibitor, also exerts vasodilatory, anti-inflammatory, and antiapoptotic effects. CO-releasing molecules have therapeutic value, increasing phagocytosis and reducing sepsis-induced lethality. Here we identify for the first time the bacterial targets of Ru(CO)(3)Cl(glycinate) (CORM-3), a ruthenium-based carbonyl that liberates CO rapidly under physiological conditions. Contrary to the expectation that CO would be preferentially inhibitory at low oxygen tensions or anaerobically, Escherichia coli cultures were also sensitive to CORM-3 at concentrations equimolar with oxygen. CORM-3, assayed as ruthenium, was taken up by bacteria and rapidly delivered CO intracellularly to terminal oxidases. Microarray analysis of CORM-3-treated cells revealed extensively modified gene expression, notably down-regulation of genes encoding key aerobic respiratory complexes. Genes involved in metal metabolism, homeostasis, or transport were also differentially expressed, and free intracellular zinc levels were elevated. Probabilistic modeling of transcriptomic data identified the global transcription regulators ArcA, CRP, Fis, FNR, Fur, BaeR, CpxR, and IHF as targets and potential CO sensors. Our discovery that CORM-3 is an effective inhibitor and global regulator of gene expression, especially under aerobic conditions, has important implications for administration of CO-releasing agents in sepsis and inflammation.


Subject(s)
Anti-Bacterial Agents/pharmacology , Carbon Monoxide/pharmacology , Escherichia coli K12/metabolism , Escherichia coli Proteins/biosynthesis , Gene Expression Regulation, Bacterial/drug effects , Organometallic Compounds/pharmacology , Transcription Factors/biosynthesis , Anaerobiosis/drug effects , Anaerobiosis/physiology , Anti-Bacterial Agents/metabolism , Carbon Monoxide/metabolism , Escherichia coli K12/genetics , Escherichia coli Proteins/genetics , Gene Expression Profiling , Oligonucleotide Array Sequence Analysis , Organometallic Compounds/metabolism , Transcription Factors/genetics
5.
Anal Bioanal Chem ; 391(6): 1997-2003, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18414834

ABSTRACT

A new environmental certified reference material (CRM) for the determination of multielements in aerosol particulate matter has been developed and certified by the National Institute for Environmental Studies (NIES), Japan, based on analyses by a network of laboratories using a wide range of methods. The origin of the material was atmospheric particulate matter collected on filters in a central ventilating system in a building in Beijing city centre. The homogeneity and stability of this material were sufficient for its use as a reference material. Values for elemental mass fractions in the material were statistically determined based on the analytical results of the participating laboratories. Eighteen certified values and 14 reference values were obtained. The diameters, obtained from a micrographic image using image analysis software, of 99% of the particles were less than 10 microm, demonstrating that almost all the particles in the material could be classified as particles of 10 microm or less in aerodynamic diameter. The chemical composition and particle size distribution of this material were close to those of an authentic aerosol collected in Beijing. NIES CRM 28 is appropriate for use in analytical quality control and in the evaluation of methods used in the analysis of aerosols, particularly those collected in urban environments in northeast Asia.

7.
Anal Biochem ; 346(2): 225-33, 2005 Nov 15.
Article in English | MEDLINE | ID: mdl-16214103

ABSTRACT

Laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) has been developed as a new strategy for detection and imaging of beta-amyloid protein in immunohistochemical sections from the brains of a transgenic mouse model of Alzheimer's disease. The distribution of beta-amyloid deposits in tissue was based on measurement of Eu- and Ni-coupled antibodies. The laser-based methodologies (spot ablation, single line raster, and two-dimensional imaging) were also used to detect and map trace element distributions and thus provide a novel probe for both elemental and protein data. We also report the combination of laser capture microdissection with LA-ICP-MS as an alternative strategy for microanalysis of immunohistochemical sections.


Subject(s)
Alzheimer Disease/pathology , Amyloid beta-Peptides/analysis , Europium/analysis , Mass Spectrometry/methods , Nickel/analysis , Plaque, Amyloid/chemistry , Amyloid beta-Peptides/immunology , Animals , Brain/pathology , Brain Chemistry , Isotopes , Lasers , Mice , Mice, Transgenic
8.
Kidney Int ; 67(5): 1830-6, 2005 May.
Article in English | MEDLINE | ID: mdl-15840030

ABSTRACT

BACKGROUND: Lanthanum carbonate has been shown to be a safe, effective phosphate-binding agent. We have shown that an impaired mineralization in chronic renal failure rats treated with high doses of lanthanum carbonate develops secondary to phosphate depletion and is therefore pharmacologically mediated rather than a direct effect of lanthanum on bone. Although bulk bone lanthanum concentrations are low, it is important to consider the localization within a given tissue. METHODS: Using the scanning x-ray micro-fluorescence set-up at beamline ID21 of the European Synchrotron Radiation Facility, calcium and lanthanum distributions in bone samples were mapped. RESULTS: In chronic renal failure rats loaded orally with lanthanum carbonate (12 weeks) (2000 mg/kg/day), bulk bone lanthanum concentrations reached values up to 5 microg/g wet weight. Lanthanum could be demonstrated at the edge of the mineralized bone, at both actively mineralizing and quiescent sites, independent of the type of bone turnover. In the presence of hyperparathyroid bone disease, lanthanum was also distributed throughout the mineralized trabecular bone. No correlation with the presence of osteoid, or the underlying bone pathology could be demonstrated. After a 2- or 4-week washout period before sacrifice, lanthanum localization did not change significantly. CONCLUSION: The comparable localization of lanthanum in different types of bone turnover, and the unchanged localization after washout and consequent disappearance of the mineralization defect, indicates no relationship between the localization of lanthanum in bone and the presence of a mineralization defect.


Subject(s)
Bone and Bones/drug effects , Bone and Bones/metabolism , Kidney Failure, Chronic/drug therapy , Kidney Failure, Chronic/metabolism , Lanthanum/administration & dosage , Lanthanum/pharmacokinetics , Administration, Oral , Animals , Bone Density/drug effects , Chronic Kidney Disease-Mineral and Bone Disorder/drug therapy , Chronic Kidney Disease-Mineral and Bone Disorder/metabolism , Chronic Kidney Disease-Mineral and Bone Disorder/pathology , Lanthanum/toxicity , Male , Phosphates/metabolism , Rats , Rats, Wistar , Spectrometry, X-Ray Emission , Tissue Distribution
9.
Kidney Int ; 64(5): 1755-64, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14531808

ABSTRACT

BACKGROUND: We have previously shown that the rat kidney reabsorbs metabolically significant amounts of iron and that it expresses the divalent metal transporter 1, DMT1. The Belgrade (b) rat carries a mutation in DMT1 gene, which causes hypochromic, microcytic anemia due to impaired intestinal iron absorption and transport of iron out of the transferrin cycle endosome. In the duodenum of b/b rats, expression of DMT1 mRNA and protein is increased, suggesting a feedback regulation by iron stores. The aim of this study was to investigate iron handling and DMT1 expression in the kidneys of Belgrade rats. METHODS: Animals were maintained for 3 weeks on a synthetic diet containing 185 mg/kg iron (FeSO4), after which functional and molecular parameters were analyzed in male heterozygous (+/b) and homozygous (b/b) rats (N = 4 to 6 for each group). RESULTS: Serum iron concentration was significantly higher in b/b compared to +/b rats while urinary iron excretion rates were unchanged in b/b compared to +/b rats. Northern analysis using a rat DMT1 probe showed comparable mRNA levels between +/b and b/b animals. Western analysis and immunofluorescence microscopy performed using a polyclonal antibody against rat DMT1 showed that DMT1-specific immunoreactivity was almost absent in the kidneys of b/b rats compared to that seen in +/b animals. CONCLUSION: Our results indicate that the G185R mutation of DMT1 causes protein instability in the kidneys of b/b rats. Given that +/b and b/b rats excrete comparable amounts of iron, the lack of DMT1 protein is compensated by an alternative, yet to be identified, mechanism.


Subject(s)
Anemia/metabolism , Cation Transport Proteins/genetics , Cation Transport Proteins/metabolism , Iron-Binding Proteins/genetics , Iron-Binding Proteins/metabolism , Iron/blood , Iron/urine , Kidney/metabolism , Anemia/pathology , Animals , Drinking , Eating , Feces , Female , Kidney/pathology , Magnesium/blood , Male , Point Mutation , Potassium/blood , RNA, Messenger/analysis , Rats , Rats, Mutant Strains , Urine
10.
Am J Physiol Renal Physiol ; 285(6): F1050-9, 2003 Dec.
Article in English | MEDLINE | ID: mdl-12876064

ABSTRACT

Divalent metal transporter1 (DMT1; also known as DCT1 or NRAMP2) is an important component of the cellular machinery responsible for dietary iron absorption in the duodenum. DMT1 is also highly expressed in the kidney where it has been suggested to play a role in urinary iron handling. In this study, we determined the effect on renal DMT1 expression of feeding an iron-restricted diet (50 mg/kg) or an iron-enriched diet (5 g/kg) for 4 wk and measured urinary and fecal iron excretion rates. Feeding the low-iron diet caused a reduction in serum iron concentration and fecal iron output rate with an increase in renal DMT1 expression. Feeding an iron-enriched diet had the converse effect. Therefore, DMT1 expression in the kidney is sensitive to dietary iron intake, and the level of expression is inversely related to the dietary iron content. Changes in DMT1 expression occurred intracellularly in the proximal tubule and in the apical membrane and subapical region of the distal convoluted tubule. Increased DMT1 expression was accompanied by a decrease in urinary iron excretion rate and vice versa when DMT1 expression was reduced. Together, these findings suggest that modulation of renal DMT1 expression may influence renal iron excretion rate.


Subject(s)
Cation Transport Proteins/metabolism , Iron, Dietary/pharmacokinetics , Iron-Binding Proteins/metabolism , Kidney/metabolism , Animals , Cation Transport Proteins/biosynthesis , Diet , Immunohistochemistry , Iron, Dietary/urine , Iron-Binding Proteins/biosynthesis , Kidney/drug effects , Male , Rats , Rats, Wistar
11.
Mol Microbiol ; 44(5): 1269-86, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12028379

ABSTRACT

The Staphylococcus aureus DtxR-like protein, MntR, controls expression of the mntABC and mntH genes, which encode putative manganese transporters. Mutation of mntABC produced a growth defect in metal-depleted medium and increased sensitivity to intracellularly generated superoxide radicals. These phenotypes resulted from diminished uptake of manganese and were rescued by the addition of excess Mn(II). Resistance to superoxide was incompletely rescued by Mn(II) for STE035 (mntA mntH), and the strain had reduced virulence in a murine abscess model of infection. Expression of mntABC was repressed by Mn(II) in an MntR-dependent manner, which contrasts with the expression of mntH that was not repressed in elevated Mn(II) and was decreased in an mntR mutant. This demonstrates that MntR acts as a negative and positive regulator of these loci respectively. PerR, the peroxide resistance regulon repressor, acts with MntR to control the expression of mntABC and manganese uptake. The expression of the PerR-regulated genes, katA (catalase), ftn (ferritin) and fur (ferric uptake regulator), was diminished in STE031 (mntR) when grown in excess Mn(II). Therefore, the control of Mn(II)-regulated members of the PerR regulon and the Fur protein is modulated by MntR through its control of Mn(II) uptake. The co-ordinated regulation of metal ion homeostasis and oxidative stress resistance via the regulators MntR, PerR and Fur of S. aureus is discussed.


Subject(s)
Bacterial Proteins/metabolism , Gene Expression Regulation, Bacterial , Manganese/metabolism , Regulon/genetics , Repressor Proteins/metabolism , Staphylococcus aureus/genetics , Staphylococcus aureus/metabolism , Superoxides/metabolism , Transcription Factors , Animals , Bacterial Proteins/genetics , Base Sequence , Endothelium, Vascular/cytology , Endothelium, Vascular/metabolism , Endothelium, Vascular/microbiology , Genes, Bacterial , Genes, Reporter , Herbicides/pharmacology , Homeostasis , Humans , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Paraquat/pharmacology , Promoter Regions, Genetic , Recombinant Fusion Proteins , Repressor Proteins/genetics , Staphylococcus aureus/drug effects , Staphylococcus aureus/pathogenicity
SELECTION OF CITATIONS
SEARCH DETAIL
...